Skip to main content

JANE STREET GROUP, LLC

Position in QNCX — Quince Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in QNCX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$229,957
-$1,515,633 QoQ
Shares Held
12,642
+385.3% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 25 holders
Holding Since
Sep 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in QNCX Over Time

Shares Held

Position Value (USD)

Derivatives in QNCX

reported options exposure · as of Mar 31, 2022
CallValue
$300,834
CallShares
243
PutValue
$141,751
PutShares
114

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. QNCX ranks #162 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in QNCX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $229,957 12,642
2025-12-31 $1,745,590 521,072
2025-09-30 $57,310 35,160
2024-12-31 $19,588 10,475
2023-12-31 $125,728 119,741
2023-09-30 $84,991 75,885
2022-03-31 $141,751 22,900
2022-03-31 $300,834 48,600
2021-12-31 $1,132,014 89,700
2021-12-31 $678,248 53,744
2021-12-31 $2,057,060 163,000
2021-09-30 $7,021,156 76,600
2021-09-30 $2,135,219 23,295
2021-09-30 $6,645,350 72,500
2021-06-30 $450,500 8,500
2020-09-30 $661,000 13,220